Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation
Open Access
- 1 May 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 77 (5) , 1269-1277
- https://doi.org/10.1093/ajcn/77.5.1269
Abstract
Background: Homocysteine metabolism may be impaired in chronic liver disease, possibly contributing to fibrogenesis and disease complications. Objective: The goal was to investigate the prevalence and determinants of basal and postprandial hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation (OLT). Design: This was a cross-sectional study of 323 patients with chronic liver disease (93 with hepatitis, 8 with fatty liver, 168 with cirrhosis, and 54 after OLT) and 25 healthy control subjects. Portohepatovenous gradients of total homocysteine (tHcy) and methionine and postload methionine and tHcy kinetics before and after 10 d of supplementation with folate plus vitamin B-6 were investigated in subgroups. Results: Basal hyperhomocysteinemia was observed in all patient groups (34% of patients with hepatitis, 50% with fatty liver, 54% with cirrhosis, and 52% after OLT). It was more frequently seen in patients with elevated plasma creatinine concentrations and at advanced stages of liver disease. Mean plasma folate was normal in patients with liver disease, but vitamin B-12 was elevated in cirrhosis and vitamin B-6 was low after OLT. There were significant negative associations between tHcy and folic acid or vitamin B-12 concentrations in control subjects and in patients with hepatitis and after OLT. No systematic association between portohepatovenous differences in tHcy and methionine concentrations was found. Cirrhosis was accompanied by impaired methionine clearance. After vitamin supplementation, the area under the tHcy curve improved in cirrhosis at nearly unchanged basal tHcy concentrations. Conclusions: Basal hyperhomocysteinemia is seen in ≈50% of patients with cirrhosis and after OLT. Basal tHcy concentrations do not change significantly after supplementation with folate and vitamin B-6, but postprandial Hcy metabolism improves.Keywords
This publication has 36 references indexed in Scilit:
- Hyperhomocysteinemia in Liver CirrhosisHypertension, 2001
- An alternative view of homocysteineThe Lancet, 1999
- Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
- Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitusKidney International, 1999
- Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-α with and without supplementation with N-acetylcysteineJournal of Hepatology, 1998
- Glutathione kinetics in normal man and in patients with liver cirrhosisJournal of Hepatology, 1997
- Serial measures of plasma homocyst(e)ine after acute myocardial infarctionThe American Journal of Cardiology, 1996
- Plasma Homocysteine in the Acute and Convalescent Phases After StrokeStroke, 1995
- Hydrolysis of pyridoxal-5'-phosphate in plasma in conditions with raised alkaline phosphate.Gut, 1980
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973